PFOS disrupts key developmental pathways during hiPSC-derived cardiomyocyte differentiation in vitro - Université de Rennes Accéder directement au contenu
Article Dans Une Revue Toxicology in Vitro Année : 2022

PFOS disrupts key developmental pathways during hiPSC-derived cardiomyocyte differentiation in vitro

Résumé

Exposure to perfluorooctanesulfonic acid (PFOS) has been associated with congenital heart disease (CHD) and decreased birth weight. PFOS exposure can disrupt signaling pathways relevant for cardiac development in stem cell-derived cardiomyocyte assays, such as the PluriBeat assay, where spheroids of human induced pluripotent stem cells (hiPSCs) differentiate into contracting cardiomyocytes. Notably, cell line origin can also affect how the assay responds to chemical exposure. Herein, we examined the effect of PFOS on cardiomyocyte differentiation by transcriptomics profiling of two different hiPSC lines to see if they exhibit a common pattern of disruption. Two stages of differentiation were investigated: the cardiac progenitor stage and the cardiomyocyte stage. Many differentially expressed genes (DEGs) were observed between cell lines independent of exposure. However, 135 DEGs were identified as common between the two cell lines. Of these, 10 DEGs were associated with GO-terms related to the heart. PFOS exposure disrupted multiple signaling pathways relevant to cardiac development, including WNT, TGF, HH, and EGF. Of these pathways, genes related to the non-canonical WNTCa(2+) signaling was particularly affected. PFOS thus has the capacity to disrupt pathways important for cardiac development and function.
Fichier principal
Vignette du fichier
Davidsen et al. - 2022 - PFOS disrupts key developmental pathways during hi.pdf (6.28 Mo) Télécharger le fichier
ScienceDirect_files_14Oct2022_13-37-58.530.zip (12.85 Mo) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

hal-03789883 , version 1 (14-10-2022)

Licence

Paternité

Identifiants

Citer

Nichlas Davidsen, Louise Ramhøj, Indusha Kugathas, Bertrand Evrard, Thomas A Darde, et al.. PFOS disrupts key developmental pathways during hiPSC-derived cardiomyocyte differentiation in vitro. Toxicology in Vitro, 2022, 85, pp.105475. ⟨10.1016/j.tiv.2022.105475⟩. ⟨hal-03789883⟩
30 Consultations
24 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More